openPR Logo
Press release

Bovine Respiratory Disease Treatment Market by Top International Players are Zoetis, Intervet Inc., Virbac, Boehringer Ingelheim International GmbH, Ceva, Elanco, Vetoquinol S.A., Bimeda, Inc, Bayer AG Forecast to 2026

06-08-2021 07:30 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Bovine Respiratory Disease Treatment Market by Top

The increasing prevalence of several causative agents among animals is predicted to enable the growth of the market in the forthcoming years, says Fortune Business Insights™ in a report, titled “Bovine Respiratory Disease Treatment” Market Size, Share and Global Trend By Disease (Diphtheria, Lower Respiratory Tract Infection, Upper Respiratory Tract Infection), By Treatment (Vaccinations, Antibiotics, Immunomodulators, Nonsteroidal Anti-Inflammatory Drugs, Others), By End User (Veterinary Hospitals, Veterinary Clinics, Others), and Geography Forecast till 2026” the growing awareness regarding animal health and welfare is expected to spur new growth opportunities for the market in the foreseeable future.

Leading Players operating in the Bovine Respiratory Disease Treatment Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Zoetis
Intervet Inc.
Virbac
Boehringer Ingelheim International GmbH
Ceva
Elanco
Vetoquinol S.A.
Bimeda, Inc.
Bayer AG
And others.
Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bovine-respiratory-disease-treatment-market-100684

Bovine Respiratory Disease (BRD) refers to one of the most common and expensive diseases to occur to cattle worldwide. The bovine respiratory disease is also called a disease complex, due to the variety of causes such as various pathogens leading to its occurrence in bovines. According to the estimates of the Beef Cattle Research Council, Bovine respiratory disease accounts for 65-80% of the morbidity and 45-75% of the mortality in the feed yards. Bovine respiratory disease occurs due to various infections including viruses, bacteria and parasites viruses, includes bovine herpesvirus (IBR); bovine parainfluenza virus (PI-3), bovine respiratory syncytial virus (BRSV); bovine viral diarrhea virus (BVD), and bovine coronavirus (BCV).

Global Bovine Respiratory Disease Treatment Market Highlights:

The Bovine Respiratory Disease Treatment Market report offers an in-depth analysis of the Bovine Respiratory Disease Treatment industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Bovine Respiratory Disease Treatment market concentration, and maturity analysis is elaborated in this report.

Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.

Launch of Respiratory Vaccine by Boehringer Ingelheim International GmbH to propel Business Opportunities

The launch of the Bovalto Respi Intranasal is predicted to enable healthy growth of the market in the forthcoming years. For instance, In September 2018, Boehringer Ingelheim International GmbH. launched Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against the viruses Parainfluenza 3 Virus (PI3V) and Bovine Respiratory Syncytial Virus (BRSV). Furthermore, the launch of the Whisper Veterinary Stethoscope System is predicted to uplift the bovine respiratory disease treatment market share in the foreseeable future. For instance, In September 2017, Merck Animal Health announced the launch of the Whisper Veterinary Stethoscope System, a tool specifically designed to evaluate lung disease severity and for more accurate diagnosis of bovine respiratory disease (BRD).

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/bovine-respiratory-disease-treatment-market-100684 

Increasing Prevalence of Bovine Respiratory Disease to Boost Growth in North America

Geographically, the market is classified into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America dominated the global bovine respiratory disease treatment market in 2018 and is expected to proliferate during the forecast period, due to the large bovine animal pool, increasing prevalence of the bovine respiratory disease, and increasing expenditure on bovine health. Asia Pacific is anticipated to grow at a significant rate. The large livestock animal pool and rising incidences of bovine disorders such as bovine respiratory disease is expected to boost bovine respiratory disease treatment market trends in Asia Pacifci. Additionally, increasing awareness of animal welfare and introduction of government initiatives towards the treatment of bovine respiratory diseases are factor expected to further aid the market in Asia Pacific.

Reasons to Purchase this Report:

Comprehensive analysis of the Bovine Respiratory Disease Treatment Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/bovine-respiratory-disease-treatment-market-100684

Table Of Content:

1 Market Overview

1.1 Bovine Respiratory Disease Treatment Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2020-2026)

1.4.1.2 Canada Market States and Outlook (2020-2026)

1.4.1.3 Mexico Market States and Outlook (2020-2026)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2020-2026)

1.4.2.2 France Market States and Outlook (2020-2026)

1.4.2.3 UK Market States and Outlook (2020-2026)

1.4.2.4 Russia Market States and Outlook (2020-2026)

1.4.2.5 Italy Market States and Outlook (2020-2026)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2020-2026)

1.4.3.2 Japan Market States and Outlook (2020-2026)

1.4.3.3 Korea Market States and Outlook (2020-2026)

1.4.3.4 India Market States and Outlook (2020-2026)

1.4.3.5 Southeast Asia Market States and Outlook (2020-2026)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2020-2026)

1.4.4.2 Egypt Market States and Outlook (2020-2026)

1.4.4.3 Saudi Arabia Market States and Outlook (2020-2026)

1.4.4.4 South Africa Market States and Outlook (2020-2026)

1.4.4.5 Turkey Market States and Outlook (2020-2026)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

3 Global Bovine Respiratory Disease Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Bovine Respiratory Disease Treatment Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Bovine Respiratory Disease Treatment Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Bovine Respiratory Disease Treatment Manufacturer Market Share in 2018

3.3.2 Top 6 Bovine Respiratory Disease Treatment Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Bovine Respiratory Disease Treatment Market Analysis by Regions

4.1 Global Bovine Respiratory Disease Treatment Sales, Revenue and Market Share by Regions

4.1.1 Global Bovine Respiratory Disease Treatment Sales and Market Share by Regions (2020-2028)

4.1.2 Global Bovine Respiratory Disease Treatment Revenue and Market Share by Regions (2020-2028)

4.2 North America Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

4.3 Europe Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

4.4 Asia-Pacific Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

4.5 South America Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

4.6 Middle East and Africa Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

5 North America Bovine Respiratory Disease Treatment by Country

5.1 North America Bovine Respiratory Disease Treatment Sales, Revenue and Market Share by Country

5.1.1 North America Bovine Respiratory Disease Treatment Sales and Market Share by Country (2020-2028)

5.1.2 North America Bovine Respiratory Disease Treatment Revenue and Market Share by Country (2020-2028)

5.2 United States Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

5.3 Canada Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

5.4 Mexico Bovine Respiratory Disease Treatment Sales and Growth Rate (2020-2028)

8 South America Bovine Respiratory Disease Treatment by Country

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bovine Respiratory Disease Treatment Market by Top International Players are Zoetis, Intervet Inc., Virbac, Boehringer Ingelheim International GmbH, Ceva, Elanco, Vetoquinol S.A., Bimeda, Inc, Bayer AG Forecast to 2026 here

News-ID: 2300182 • Views: 467

More Releases from Fortune Business Insights

What's driving the Animal Health Market Growth? Prominent Players: Emergent BioS …
The global “Animal Health Marketing” is anticipated to reach USD 67.56 billion by 2026 owing to the increasing number of animal health issues worldwide. Animals have always been of immense help to man either as companions or as livestock. With time, man starting adopting animals and keeping them as pets. Animals, alike humans, are susceptible to infections and diseases and require medical aid. As per a recently published report by
What is behind the Rise of the Hereditary Angioedema Treatment Market by Top Key …
Hereditary Angioedema Treatment Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The global “Hereditary Angioedema Treatments” market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, “Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel
Contraceptive Pills Market Size, Revenue, Growth Development, Opportunities, Tre …
The global “contraceptive pills market” size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed
Orthopedic Implants Market to Expand with Rising Prevalence of Obesity in the Wo …
The global “Orthopedic Implants Market Size” is set to touch USD 64.0 billion by 2026, exhibiting a modest CAGR of 4.1% during the forecast period. Unprecedented rise in geriatric population across the globe to be the key growth driver of this market. According to the United States Census Bureau (USCB), the proportion of aged people to the total world population is steadily climbing. For example, in 2012, world population had

All 5 Releases


More Releases for Respi

Veterinary Vaccines Market: Soaring Incidences of Animal to Human Communicable A …
Surged prevalence of animal to human communicable ailments and increased demand for livestock for economic progress are noted drivers of growth for veterinary vaccines market. Additionally, soaring preferences for pet animals owing to superlative lifestyle across economies further facilitate growth of veterinary vaccines market. A new report titled, 'Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026' collated in the vast repository of Market
Respiratory Syncytial Virus Diagnostics Industry Trends, Analysis To 2022 by Gra …
Global Respiratory Syncytial Virus (RSV) diagnostics market is expected to reach USD 1.2 billion by 2022, according to a new study by Grand View Research Inc. Increasing neonatal population suffering from respiratory conditions including RSV infections and supportive initiatives for diagnosis of newborns by the healthcare providers are expected to be vital impact rendering drivers for RSV diagnostics market. According to the statistics provided by the WHO, hospitalization of over 150,000